Showing results (41-50 of 52) with videos related to
Sort By:
Pageof 6
Circulation|May 10, 2022
Rapid Exclusion of Acute Myocardial Injury and Infarction With a Single High-Sensitivity Cardiac Troponin T in the Emergency Department: A Multicenter United States EvaluationYader Sandoval, Bradley R Lewis, Ramila A Mehta, et al.European Journal of Heart Failure|May 5, 2022
Incidence and risk factors for pacemaker implantation in light-chain and transthyretin cardiac amyloidosisAldostefano Porcari, Maddalena Rossi, Francesco Cappelli, et al.JACC. Cardiooncology|November 29, 2022
Low QRS Voltages in Cardiac Amyloidosis: Clinical Correlates and Prognostic ValueAlberto Cipriani, Laura De Michieli, Aldostefano Porcari, et al.Circulation. Heart Failure|May 15, 2025
High-Sensitivity Cardiac Troponin I for Risk Stratification in Wild-Type Transthyretin Amyloid CardiomyopathyLaura De Michieli, Giulio Sinigiani, Gianluigi Guida, et al.Journal of the American College of Cardiology|March 26, 2024
Stratifying Disease Progression in Patients With Cardiac ATTR AmyloidosisAdam Ioannou, Francesco Cappelli, Michele Emdin, et al.European Heart Journal. Quality of Care & Clinical Outcomes|May 20, 2025
Change in prevalence of ATTR variants in Italy - Results from a National SurveyCarlo Fumagalli, Simone Longhi, Alberto Aimo, et al.European Heart Journal|April 9, 2026
Cascade genetic screening in families with hereditary transthyretin amyloidosis: diagnostic and prognostic impactFrancesco Cappelli, Carlo Fumagalli, Marco Luigetti, et al.European Journal of Heart Failure|November 29, 2025
Clinical phenotype and prognosis of real-world patients with wild-type transthyretin amyloid cardiomyopathy treated with tafamidisAldostefano Porcari, Paolo Milani, Simone Longhi, et al.ESC Heart Failure|September 20, 2024
Early diagnosis, disease stage and prognosis in wild-type transthyretin amyloid cardiomyopathy: The DIAMOND studyGiacomo Tini, Beatrice Musumeci, Paolo Milani, et al.European Journal of Heart Failure|March 12, 2023
Diagnostic pathways to wild-type transthyretin amyloid cardiomyopathy: a multicentre network studyGiacomo Tini, Paolo Milani, Mattia Zampieri, et al.Pageof 6